Epidemiology and Health

Original Article

Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort study: Erdaw Tachbele, Gobena Ameni; Epidemiol Health. 2016;38:e2016049. Published online November 6, 2016; DOI: https://doi.org/10.4178/epih.e2016049

18,925 View
375 Download
26 Web of Science
11 Crossref

Abstract

OBJECTIVES
The survival rate of human immunodeficiency virus (HIV)-infected patients receiving treatment in Ethiopia is poorly understood. This study aimed to determine the survival rate and predictors of mortality among HIV-infected adults on antiretroviral therapy (ART) at Jinka Hospital, South Omo, Ethiopia.

METHODS

A 6-year retrospective cohort study was conducted using 350 patient records drawn from 1,899 patients on ART at Jinka Hospital from September 2010 to August 2015. The data were analyzed using Kaplan-Meier statistics and Cox regression models.

RESULTS

Of the 350 study participants, 315 (90.0%) were censored and 35 (10.0%) died. Twenty-two (62.9%) of the deaths occurred during the first year of treatment. The total follow-up encompassed 1,995 person-years, with an incidence rate of 1.75 deaths per 100 person-years. The mean survival time of patients on highly active antiretroviral therapy (HAART) was 30.84±19.57 months. The overall survival of patients on HAART was 64.00% (95% confidence interval [CI], 61.85 to 66.21%) at 72 months of follow-up. The significant predictors of mortality included non-disclosure of HIV status (adjusted hazard ratio [aHR], 5.82; 95% CI, 1.91 to 17.72), a history of tuberculosis (aHR, 1.82; 95% CI, 1.41 to 3.51), and ambulatory (aHR, 2.97; 95% CI, 1.20 to 8.86) or bedridden (aHR, 4.67; 95% CI, 1.30 to 17.27) functional status, World Health Organization (WHO) clinical stage IV illness (aHR, 24.97; 95% CI, 2.75 to 26.45), and substance abusers (aHR, 3.72; 95% CI, 1.39 to 9.97).

CONCLUSIONS

Patients with a history of tuberculosis treatment, ambulatory or bedridden functional status, or advanced WHO clinical stage disease, as well substance abusers, should be carefully monitored, particularly in the first few months after initiating antiretroviral therapy. Patients should also be encouraged to disclose their status to their relatives.

Summary

Citations

Citations to this article as recorded by

Incidence rate of mortality and its predictors among tuberculosis and human immunodeficiency virus coinfected patients on antiretroviral therapy in Ethiopia: systematic review and meta-analysis
Nebiyu Mekonnen Derseh, Muluken Chanie Agimas, Fantu Mamo Aragaw, Tilahun Yemanu Birhan, Solomon Gedlu Nigatu, Meron Asmamaw Alemayehu, Tigabu Kidie Tesfie, Tirualem Zeleke Yehuala, Tilahun Nega Godana, Mehari Woldemariam Merid
Frontiers in Medicine.2024;[Epub] CrossRef
Predictors of Survival Time Among HIV-Infected Adults After Initiating Anti-Retroviral Therapy in Kombolcha Town: A 5-Year Retrospective Cohort Study
Muhammed Siraj, Sisay Gedamu, Belachew Tegegne
HIV/AIDS - Research and Palliative Care.2022; Volume 14: 181. CrossRef
Survival and predictors of mortality among HIV-infected adults receiving ART in Hawassa comprehensive specialized hospital, Sidama regional state, Ethiopia
Balta Bargude, Fanta Amanuel
Journal of Advanced Pediatrics and Child Health.2022; 5(1): 042. CrossRef
Incidence of Mortality and Its Predictors Among HIV Positive Adults on Antiretroviral Therapy in University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia
Achamyeleh Birhanu Teshale, Adino Tesfahun Tsegaye, Haileab Fekadu Wolde
HIV/AIDS - Research and Palliative Care.2021; Volume 13: 31. CrossRef
Statistical Joint Modeling for Predicting the Association of CD4 Measurement and Time to Death of People Living with HIV Who Enrolled in ART, Southwest Ethiopia
Firew Tiruneh, Lalisa Chewaka, Dinaol Abdissa
HIV/AIDS - Research and Palliative Care.2021; Volume 13: 73. CrossRef
Rate and Predictors of Mortality Among Adults on Antiretroviral Therapy at Debre Markos Referral Hospital, North West Ethiopia
Haddis Birhanu, Atsede Alle, Molla Yigzaw Birhanu
HIV/AIDS - Research and Palliative Care.2021; Volume 13: 251. CrossRef
Predictors of Mortality Among Adult HIV-Infected Patients Taking Antiretroviral Therapy (ART) in Harari Hospitals, Ethiopia
Abdi Birhanu, Tariku Dingeta, Moti Tolera
HIV/AIDS - Research and Palliative Care.2021; Volume 13: 727. CrossRef
Epidemiology of survival pattern and its predictors among HIV positive patients on highly active antiretroviral therapy in Southern Ethiopia public health facilities: a retrospective cohort study
Abewa Kebede, Fasil Tessema, Gadisa Bekele, Zerihun Kura, Hailu Merga
AIDS Research and Therapy.2020;[Epub] CrossRef
Prognostic Factors of Mortality among Adult Patients on Antiretroviral Therapy in India: A Hospital Based Retrospective Cohort Study
Nitin Joseph, Ushasti Sinha, Nishtha Tiwari, Pritha Ghosh, Patneedi Sindhu
BioMed Research International.2019; 2019: 1. CrossRef
Predictors of mortality among adult patients enrolled on Antiretroviral Therapy in Hiwotfana specialized University Hospital, Eastern Ethiopia: Retrospective Cohort study
Eticha Endalkachew Mekonnen
Journal of HIV for Clinical and Scientific Research.2018; : 007. CrossRef
Prevalence and Risk Factors of Mortality among Adult HIV Patients Initiating ART in Rural Setting of HIV Care and Treatment Services in North Western Tanzania: A Retrospective Cohort Study
Daniel Wilfred Gunda, Igembe Nkandala, Semvua Bukheti Kilonzo, Boniface Bartholomew Kilangi, Bonaventura Cornel Mpondo
Journal of Sexually Transmitted Diseases.2017; 2017: 1. CrossRef

First
Prev
Page of 1
Next
Last

Search